Alibaba Group Holding Limited:企業のM&A・事業提携・投資動向

◆英語タイトル:Alibaba Group Holding Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2234
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:199
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:小売り
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Alibaba Group Holding Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Alibaba Group Holding Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Alibaba Group Holding Limited since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Alibaba Group Holding Limited’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Alibaba Group Holding Limited. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Alibaba Group Holding Limited’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Alibaba Group Holding Limited and its subsidiaries since 2007.
- Information about key financial and legal advisors for Alibaba Group Holding Limited’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Alibaba Group Holding Limited’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 6
LIST OF TABLES 8
LIST OF FIGURES 8
TARGETS AND PARTNERS 9
MERGERS & ACQUISITIONS 11
Mergers and Acquisitions – Overview 11
Mergers and Acquisitions – Deal reports 12
CORPORATE VENTURING 62
Corporate Venturing – Overview 62
Corporate Venturing – Deal reports 63
PARTNERSHIP 158
Partnership – Overview 158
Partnership – Deal reports 159
CAPITAL RAISING 161
Capital Raising – Overview 161
Capital Raising – Deal reports 162
DIVESTMENTS 182
Divestments – Overview 182
Divestments – Deal reports 183
PRIVATE EQUITY & OWNERSHIP 185
Private Equity and Ownership – Overview 185
Private Equity and Ownership – Deal reports 186
APPENDIX 189
Contact Us 189
About MarketLine Financial Deals Database 189
Deal Definition and Methodology 191
About MarketLine 198

List of Tables
Table 1: Alibaba Group Holding Limited M&A volume and value trend (2014-YTD2018)
Table 2: Alibaba Group Holding Limited M&A activity by geography (2014-YTD2018)
Table 3: Alibaba Group Holding Limited corporate venturing volume and value trend (2014-YTD2018)
Table 4: Alibaba Group Holding Limited corporate venturing by geography (2014-YTD2018)
Table 5: Alibaba Group Holding Limited partnership volume and value trend (2014-YTD2018)
Table 6: Alibaba Group Holding Limited partnership trend by key deal type (2014-YTD2018)
Table 7: Alibaba Group Holding Limited capital raising volume and value trend (2014-YTD2018)
Table 8: Alibaba Group Holding Limited capital raising by deal type (2014-YTD2018)
Table 9: Alibaba Group Holding Limited divestments volume and value trend (2014-YTD2018)
Table 10: Alibaba Group Holding Limited private equity and ownership volume and value trend (2014-YTD2018)
Table 11: Alibaba Group Holding Limited private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Alibaba Group Holding Limited M&A volume and value trend (2014-YTD2018)
Figure 2: Alibaba Group Holding Limited M&A activity by geography (2014-YTD2018)
Figure 3: Alibaba Group Holding Limited corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Alibaba Group Holding Limited corporate venturing by geography (2014-YTD2018)
Figure 5: Alibaba Group Holding Limited partnership volume and value trend (2014-YTD2018)
Figure 6: Alibaba Group Holding Limited partnership trend by key deal type (2014-YTD2018)
Figure 7: Alibaba Group Holding Limited capital raising volume and value trend (2014-YTD2018)
Figure 8: Alibaba Group Holding Limited capital raising by deal type (2014-YTD2018)
Figure 9: Alibaba Group Holding Limited divestments volume and value trend (2014-YTD2018)
Figure 10: Alibaba Group Holding Limited private equity and ownership volume and value trend (2014-YTD2018)
Figure 11: Alibaba Group Holding Limited private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Alibaba Group Holding Limited:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Engie SA:企業の戦略・SWOT・財務情報
    Engie SA - Strategy, SWOT and Corporate Finance Report Summary Engie SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Tsumura & co (4540):製薬・医療:M&Aディール及び事業提携情報
    Summary Tsumura & co (Tsumura) is a traditional pharmaceutical products company, which undertakes the manufacturing and sale of Kampo extract intermediates and granular Kampo formulations. Its product portfolio includes a range of prescription Kampo products, other pharmaceuticals, over-the-counter …
  • Intertech Bilgi Islem ve Pazarlama Ticaret A.S.:企業の戦略・SWOT・財務情報
    Intertech Bilgi Islem ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Intertech Bilgi Islem ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Calpine Corporation (CPN)-エネルギー分野:企業M&A・提携分析
    Summary Calpine Corporation (Calpine) is an electric and natural gas utility. The company produces electricity and thermal energy from natural gas, geothermal, and solar sources. It uses natural gas-fired combustion and renewable geothermal conventional steam turbine technologies to generate energy. …
  • Schweitzer-Mauduit International Inc (SWM):企業の財務・戦略的SWOT分析
    Schweitzer-Mauduit International Inc (SWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Edgemont Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Edgemont Pharmaceuticals LLC (Edgemont) is a pharmaceutical company that develops, acquires, and markets products for the treatment of psychiatric disorders. The company focuses on the development of novel drug formulations and therapies in the field of neuroscience. Its portfolio of product …
  • Dana-Farber Cancer Institute Inc-医療機器分野:企業M&A・提携分析
    Summary Dana-Farber Cancer Institute Inc (Dana-Farber), formerly Sidney Farber Cancer Center is a cancer research center that offers treatment for different types of cancers. The center offers adults and children with various treatment options and also focuses on diagnosis, treatment, cure, and prev …
  • Regeneron Pharmaceuticals Inc (REGN):企業の財務・戦略的SWOT分析
    Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Almac Discovery Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Almac Discovery Ltd (Almac Discovery) a subsidiary of Almac Group Ltd is a healthcare service provider that discovers and develops drugs for the treatment of cancer. The company develops drugs, small molecule and therapeutic peptide, biomarkers and diagnostic tools. It provides early drug di …
  • Ezaki Glico Co Ltd:企業の戦略・SWOT・財務情報
    Ezaki Glico Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Ezaki Glico Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • DLF Limited:企業の戦略・SWOT・財務情報
    DLF Limited - Strategy, SWOT and Corporate Finance Report Summary DLF Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Enstar Group Ltd.:企業のM&A・事業提携・投資動向
    Enstar Group Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Enstar Group Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Rizal Commercial Banking Corp (RCB):電力:M&Aディール及び事業提携情報
    Summary Rizal Commercial Banking Corp (RCBC) is a commercial and financial banking service provider that offers corporate, commercial, and consumer banking, cash management, treasury, and remittance products and services. The company’s electronic banking services include mobile banking, internet ban …
  • Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析
    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • WAVE Life Sciences Ltd (WVE):製薬・医療:M&Aディール及び事業提携情報
    Summary WAVE Life Sciences Ltd (WAVE Life Sciences), formerly WAVE Life Sciences Pte Ltd is a genetic medicine company that develops stereopure nucleic acid therapies. The company's pipeline products comprise multiple oligonucleotide modalities such as exon-skipping and single-stranded RNAi, and ant …
  • Sanquin Blood Supply Foundation:医療機器:M&Aディール及び事業提携情報
    Summary Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, an …
  • Graftys SA-医療機器分野:企業M&A・提携分析
    Summary Graftys SA (Graftys) is a medical device company that focuses on the development, manufacture and commercialization of synthetic bioactive orthopedic biomaterials. It provides a wide range of synthetic and bioresorbable bone graft substitutes and other cement products. The company’s products …
  • China Pacific Insurance (Group) Co Ltd:戦略・SWOT・企業財務分析
    China Pacific Insurance (Group) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Pacific Insurance (Group) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Silence Therapeutics Plc (SLN):企業の財務・戦略的SWOT分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a developer of therapeutics that channels gene silencing to cure life-threatening diseases. The company's pipeline products include SLN124, SLN500 and SLN360. Its SLN124 is developed for the treatment of cardiovascula …
  • Bio-Reference Laboratories Inc:企業の戦略的SWOT分析
    Bio-Reference Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆